test

Steve R. Bailey

@Frazier Life Sciences Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$2.495BTotal holdings53
Assets growth rate16.72%Assets growth rate (2-Q avg)3.46%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Frazier Life Sciences Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 53 positions.

Assets under management

The assets under management (AUM) of Frazier Life Sciences Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.495B in assets, with a quarterly growth rate of 16.72% and a 2-quarter average growth rate of 3.46%. The portfolio is managed by Steve R. Bailey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ARQTArcutis Biotherapeutics Inc
Recent Activity
3.28%
$81.703M
8.785M shares@ $9.3 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
Decreased -24.07%
3.04%
$75.609M
2.833M shares@ $26.69 avg price
ANABAnaptysbio Inc
Recent Activity
Increased 2.02%
2.97%
$74.008M
2.209M shares@ $33.51 avg price
ERASErasca Inc
Recent Activity
Increased 19.59%
2.13%
$52.939M
19.392M shares@ $2.74 avg price
TARSTarsus Pharmaceuticals Inc
Recent Activity
2.1%
$52.214M
1.588M shares@ $32.89 avg price
AGIOAgios Pharmaceuticals Inc
Recent Activity
Increased 19.75%
1.86%
$46.392M
1.044M shares@ $44.43 avg price
RVMDRevolution Medicines Inc
Recent Activity
1.82%
$45.235M
997,455 shares@ $45.35 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
1.78%
$44.212M
875,667 shares@ $50.5 avg price
KALVKalvista Pharmaceuticals Inc
Recent Activity
1.72%
$42.706M
3.688M shares@ $11.59 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
1.71%
$42.464M
4.143M shares@ $10.26 avg price